Matches in Wikidata for { <http://www.wikidata.org/entity/Q65391108> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q65391108 description "clinical trial" @default.
- Q65391108 description "ensayu clínicu" @default.
- Q65391108 description "klinisch onderzoek" @default.
- Q65391108 description "клінічне випробування" @default.
- Q65391108 description "կլինիկական փորձարկում" @default.
- Q65391108 name "A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma" @default.
- Q65391108 name "A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma" @default.
- Q65391108 type Item @default.
- Q65391108 label "A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma" @default.
- Q65391108 label "A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma" @default.
- Q65391108 prefLabel "A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma" @default.
- Q65391108 prefLabel "A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma" @default.
- Q65391108 P1050 Q65391108-69A904ED-6FE8-45E5-AE55-7BE17754AC37 @default.
- Q65391108 P1132 Q65391108-327BB306-004D-41A5-AC37-EF2E2E0377ED @default.
- Q65391108 P1476 Q65391108-A25752A1-7FEF-4BA8-A638-87A63C801468 @default.
- Q65391108 P2899 Q65391108-7A1FD68A-E010-4095-B417-57CBE9EEC28D @default.
- Q65391108 P3098 Q65391108-2882BB6D-8F56-4BD2-8329-8BEB42988D7E @default.
- Q65391108 P31 Q65391108-784931CC-4C40-4637-AA83-6356750DF78D @default.
- Q65391108 P4844 Q65391108-98FFE945-B64D-472B-844E-B7102C56233B @default.
- Q65391108 P580 Q65391108-4B94299A-B848-440E-8635-CB65E77C3A13 @default.
- Q65391108 P582 Q65391108-90E104E9-7BE4-4FFC-9F69-34B14257B842 @default.
- Q65391108 P6099 Q65391108-FBAD697F-BFBA-444F-9937-D955C55B94D3 @default.
- Q65391108 P8363 Q65391108-3E68D2E7-BAB4-4589-87D5-23B0D2D5C6B9 @default.
- Q65391108 P859 Q65391108-EE47BAD2-9A1C-4F5C-BCD7-D25E611293D2 @default.
- Q65391108 P1050 Q208414 @default.
- Q65391108 P1132 "+15" @default.
- Q65391108 P1476 "A Multi-Center Study to Examine the Pharmacokinetics, Whole Body and Organ Dosimetry, and Biodistribution of Fission-Derived Iodine I 131 Tositumomab for Patients With Previously Untreated or Relapsed Follicular or Transformed Follicular Non-Hodgkin's Lymphoma" @default.
- Q65391108 P2899 "+18" @default.
- Q65391108 P3098 "NCT00315731" @default.
- Q65391108 P31 Q30612 @default.
- Q65391108 P4844 Q3649449 @default.
- Q65391108 P580 "2003-03-31T00:00:00Z" @default.
- Q65391108 P582 "2006-12-04T00:00:00Z" @default.
- Q65391108 P6099 Q5452194 @default.
- Q65391108 P8363 Q78089383 @default.
- Q65391108 P859 Q212322 @default.